Catherine Lenson

Varian Semiconductor Equipment Associates, Inc. designs and manufactures semiconductor processing equipment. The company was founded in April 1999 and is headquartered in Gloucester, MA.

Goldman Sachs International (GSI) is the Great Britain-based, wholly-owned brokerage subsidiary of Goldman Sachs Group UK Ltd., ultimately held by The Goldman Sachs Group, Inc. (NYSE: GS) in the US. The firm was founded in 1988 and formerly known as Trushelfco Ltd. Headquartered in London, GSI provides prime brokerage, securities lending, futures services and financing services for a range of clients such as corporations, financial institutions, governments and high-net worth individuals.

Security Investors LLC (dba Guggenheim Investments) is a SEC-registered investment advisor headquartered in New York City. The firm was founded in 1962 and is a subsidiary of Rydex Holdings LLC, ultimately held by Guggenheim Partners LLC. Security Investors provides investment advisory services to separately managed accounts (SMAs) and pooled investment vehicles that are registered as investment companies. They focus on the return and risk needs of insurance companies, corporate and public pension funds, sovereign wealth funds, endowments and foundations, wealth managers, and high-net-worth investors.

Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry.

McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA.

Coller Capital Ltd (Coller Capital) is a private equity firm founded in 1990 by Jeremy Joseph Coller. The firm is headquartered in London with additional offices in New York, Hong Kong, Beijing, Luxembourg and Seoul.

Goldman Sachs Japan Co., Ltd. (GSJCL) is the Japan-based broker-dealer subsidiary of Goldman Sachs (Japan) Ltd., ultimately held by The Goldman Sachs Group, Inc. (NYSE: GS) in the US. The firm originated in 1974 and was formally founded in 1983. Headquartered in Tokyo, GSJCL offers Internet-based transaction services covering equity, debt, commodities and derivatives to a substantial and diversified client base, which includes corporations, financial institutions, governments and high net worth individuals.

Atomico (UK) Partners LLP (Atomico (UK) Partners) is a venture capital firm founded in 2006 by Mattias Ljungman and Niklas Mårten Zennström. The firm is headquartered in London, United Kinghdom with additional offices in Sau Paulo and New York.

Guggenheim Partners Investment Management LLC (GPIM) is a SEC-registered investment advisor headquartered in Santa Monica, California. The firm was founded by Mark Walter in 2005 and is a direct subsidiary of Guggenheim Partners Investment Management Holdings LLC, ultimately owned by Guggenheim Partners LLC. GPIM provides investment advisory and supervisory services to a variety of institutional clients through separately managed accounts (SMAs) and registered and unregistered pooled investment vehicles.

Höegh Capital Partners Ltd. (Investment Management) (HCP-IM) is the alternative investment management division of Höegh Capital Partners Ltd., an investment company headquartered in London, UK. The firm was founded by Guy Lafferty in 1990 as Lafferty & Partners Ltd., and was renamed in 1999. HCP-IM acts as financial advisor to the investment interests associated with the Höegh family and their professional partners.

Part of Freshfields Bruckhaus Deringer LLP, Freshfields Bruckhaus Deringer LLP (Hong Kong) provides legal services. The company is based in Hong Kong, Hong Kong.

King's College London Students' Union operates as a students' union. The non-profit company is based in London, UK. Denis Shukur has been the CEO of the British company since 2018.

Lemnos Labs Inc (Lemnos Labs) is a venture capital firm founded in 2011 by Jeremy Conrad and Helen Zelman Boniske. The firm is headquartered in San Francisco, California.

Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom.

Monograph Capital Advisors (UK) LLP (Monograph Capital) is a private equity and venture capital firm founded in 2021 by Fred Ehrenkranz Cohen and Charles Conn. The firm is headquartered in London, GB.

AviadoBio Ltd. is a gene therapy company based in London, UK. AviadoBio's technology is based on pioneering research from King's College London and the UK Dementia Research Institute. The British company's mission is to develop and deliver transformative gene therapies for neurodegenerative disorders, including frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The company is developing AVB-101 for patients with FTD-GRN. AviadoBio's investors include New Enterprise Associates (NEA), Monograph Capital, Advent Life Sciences, EQT Lifesciences, Dementia Discovery Fund (DDF), F-Prime Capital, Johnson & Johnson Innovation – JJDC, Inc. (JJDC), and LifeArc. The company was founded by Youn Bok Lee, Do Young Lee, Chris E. Shaw, and Lisa Deschamps has been the CEO of the company since 2021.

Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts.

Part of SoftBank Group Corp., SB Investment Advisers (US), Inc. provides investment advisory services. The company is based in San Carlos, CA. Eric Chen has been the CEO of the company since 2018.

HD Insurance Ltd. provides car insurance services. It covers third party liability and property damage, bodily injury, damages from an uninsured vehicle, accident care, road assistance, glass, legal protection, and personal accident. The company was founded by Emilios Markou and Alexis Pantazis in 2011 and is headquartered in Nicosia, Cyprus.

Mirobio Ltd. operates as a biologics company focusing on autoimmune and inflammatory disorders. The firm develops antibody modulators of immune cell receptors, an approach that has potential across a range of diseases, with an initial focus on auto-immune disease. The company was founded by Richard Cornall and Simon Davis on October 8, 2018 and is headquartered in Oxford, the United Kingdom.

Maxion Therapeutics is a British company that specializes in creating first-in-class and protein therapeutics for treating previously untreatable ion channel- and GPCR-driven diseases. The company was founded by John McCafferty, Aneesh Karatt-Vellatt, and is based in London, UK. The company achieves this through their revolutionary KnotBody® technology. John McCafferty has been the CEO since incorporation.

Ascend Gene & Cell Therapies Ltd. is a gene and cell therapy manufacturing specialist that aims to create effective gene therapies to a world-class standard. The company is based in Altrincham, UK, and has subsidiaries in Germany. The British company focuses on constantly refining and flexing their approach and embracing opportunities to innovate to create therapies that change lives. Ascend has over $130m of funding as expert teams merge. The company has a solid platform that allows their team to do their best work and deliver unwavering quality. Timothy Michael Funnell has been the CEO of the company since 2021.

Fynder Group, Inc. develops edible protein. The company was founded by Thomas Jonas and Yuval Avniel in 2016 and is headquartered in Chicago, IL.

Papa, Inc. engages in the development of end to end companionship platform for seniors. The firm offers airport and senior transportation, house needs, grocery shopping, and technology services. The company was founded by Andrew Parker and Alfredo Vaamonde in 2016 and is headquartered in Miami, FL.

Sourcery Technologies, Inc. develops a payments and commerce platform that focuses on the wholesale foodservice industry. Its features include invoice storage, analytics, online bill pay and high touch services. The company was founded by Na’ama Moran and Peretz Partensky in July 2012 and is headquartered in San Francisco, CA.

Pioneer Fund/NY/ is a venture capital firm founded by Jason Gray. The firm is headquartered in San Francisco, California.

ImmuneBridge, Inc. is a biotech company that is developing the next generation of allogeneic cellular medicines to make curative cancer therapies accessible to everyone. The company is based in San Francisco, CA and was founded in 2018 by Jesse Cotari and Peretz Partensky. The company is starting with NK cell-based immunotherapies. The company's proprietary expansion technology amplifies cord blood-derived immune stem cells while maintaining full immune multipotency to create a consistent and abundant cellular source for immunotherapies. ImmuneBridge's scientific approach harnesses this expansion technology along with the unique benefits of umbilical cord blood to enable robust screening and selection for the most potent cancer-fighting cells. Peretz Partensky has been the CEO since 2018.